| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Suresh K Tikoo | Q61471814 |
| Volker Gerdts | Q96650456 | ||
| George Mutwiri | Q116693068 | ||
| Lorne Babiuk | Q6681421 | ||
| P2860 | cites work | Construction and characterization of recombinant porcine adenovirus serotype 5 expressing the transmissible gastroenteritis virus spike gene | Q45739263 |
| Resistance to bovine respiratory syncytial virus (BRSV) induced in calves by a recombinant bovine herpesvirus-1 expressing the attachment glycoprotein of BRSV. | Q45754599 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 487-510 | |
| P577 | publication date | 2006-04-14 | |
| P1433 | published in | Veterinary Research | Q15761008 |
| P1476 | title | Mucosal delivery of vaccines in domestic animals | |
| P478 | volume | 37 |
| Q47548435 | A Promising Recombinant Herpesvirus of Turkeys Vaccine Expressing PmpD-N of Chlamydia psittaci Based on Elongation Factor-1 Alpha Promoter |
| Q38099839 | A review of vaccine development and research for industry animals in Korea |
| Q37112007 | Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies. |
| Q37822316 | Adjuvants and delivery systems in veterinary vaccinology: current state and future developments |
| Q98953662 | Adjuvants for swine vaccines: Mechanisms of actions and adjuvant effects |
| Q38124613 | Animal vaccines based on orally presented yeast recombinants |
| Q37279568 | Bovine neonate natural killer cells are fully functional and highly responsive to interleukin-15 and to NKp46 receptor stimulation |
| Q35609703 | Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus |
| Q36913580 | Contagious bovine pleuropneumonia: a rationale for the development of a mucosal sub-unit vaccine |
| Q27480923 | Current Status of Veterinary Vaccines |
| Q38408021 | Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens. |
| Q50112757 | Enteric Immunity: Happy Gut, Healthy Animal |
| Q90239627 | Genome-Wide Identification of Virulence Genes in Erysipelothrix rhusiopathiae: Use of a Mutant Deficient in a tagF Homolog as a Safe Oral Vaccine against Swine Erysipelas |
| Q41842167 | Gut-Associated Lymphoid Tissue: A Key Tissue Inside the Mucosal Immune System of Hens Immunized with Escherichia coli F4. |
| Q37033007 | Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection |
| Q36191640 | Immunostimulatory effects of recombinant Erysipelothrix rhusiopathiae expressing porcine interleukin-18 in mice and pigs |
| Q35575370 | In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O157:H7 for oral immunogenic applications |
| Q28658422 | Influenza viral vectors expressing the Brucella OMP16 or L7/L12 proteins as vaccines against B. abortus infection |
| Q44289404 | Intranasal immunization with a non-adjuvanted adhesive protein descended from Pasteurella pneumotropica and its preventive efficacy against opportunistic infection in mice. |
| Q28084076 | Live-Attenuated Bacterial Vectors: Tools for Vaccine and Therapeutic Agent Delivery |
| Q91775765 | Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and Infection |
| Q37123323 | Primary human leukocyte subsets differentially express vaccinia virus receptors enriched in lipid rafts |
| Q52091125 | Recombinant Lactobacillus casei expressing Clostridium perfringens toxoids α, β2, ε and β1 gives protection against Clostridium perfringens in rabbits. |
| Q30952009 | Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice |
| Q38367399 | The challenges in developing effective canine infectious respiratory disease vaccines |
| Q36657196 | The potential of oral vaccines for disease control in wildlife species |
| Q82943356 | Thermostable tag (TST) protein expression system: engineering thermotolerant recombinant proteins and vaccines |
| Q37015991 | Use of animal models in the development of human vaccines |
| Q35530231 | Use of inactivated Escherichia coli enterotoxins to enhance respiratory mucosal adjuvanticity during vaccination in swine |
| Q39390000 | Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals |
Search more.